Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists
被引:38
作者:
Fourmy, D
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Fourmy, D
Escrieut, C
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Escrieut, C
Archer, E
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Archer, E
Galès, C
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Galès, C
Gigoux, V
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Gigoux, V
Maigret, B
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Maigret, B
Moroder, L
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Moroder, L
Silvente-Poirot, S
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Silvente-Poirot, S
Martinez, J
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Martinez, J
Fehrentz, JA
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Fehrentz, JA
Pradayrol, L
论文数: 0引用数: 0
h-index: 0
机构:CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
Pradayrol, L
机构:
[1] CHU Rangueil, INSERM, U531, Louis Buhnard Inst, F-31403 Toulouse 4, France
[2] Univ Nancy, UHP, CNRS, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
[3] Max Planck Inst Biochem, D-82143 Martinsried, Germany
[4] Fac Pharm Montpellier, CNRS, UMR 5810, F-34060 Montpellier, France
来源:
PHARMACOLOGY & TOXICOLOGY
|
2002年
/
91卷
/
06期
关键词:
D O I:
10.1034/j.1600-0773.2002.910608.x
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Delineation of CCK receptor binding sites is a prerequisite for the understanding of the molecular basis for ligand recognition, partial agonism. ligand-induced traffiking of receptor signalling. In the current paper, we illustrate how, in the past 5 years, studies from our laboratory and others have provided new data on the molecular basis of the pharmacology and functioning of CCK1 and CCK2 receptors. Available data on CCK1 and CCK2R binding sites indicate that 1) homologous regions of the two receptors are involved in the binding site of CCK, however, positioning of CCK slightly differs; 2) binding sites of non-peptide agonists/antagonist are buried in the pocket formed by transmembrane helices and overlap that of CCK and 3) residues of the binding sites as well as of conserved motifs such as E/DRY, NPXXY are crucial for receptor activation.